Sherban A - Search Results

1

CT findings are highly predictive for perforation in patients with diffuse large B-cell lymphoma involving the intestines.

Sarid N, Sherban A, Bendet A, Adam S, Herishanu Y, Perry C, Avivi I. Sarid N, et al. Among authors: sherban a. Leuk Lymphoma. 2018 Aug;59(8):1878-1883. doi: 10.1080/10428194.2017.1403023. Epub 2017 Nov 27. Leuk Lymphoma. 2018. PMID: 29172816

2

Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.

Kagan KBT, Guz D, Buchrits S, Gurion R, Vaxman I, Priss M, Groshar D, Catalano OA, Sherban A, Raanani P, Gafter-Gvili A, Bernstine H. Kagan KBT, et al. Among authors: sherban a. Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2290-2299. doi: 10.1007/s00259-022-05683-2. Epub 2022 Jan 26. Eur J Nucl Med Mol Imaging. 2022. PMID: 35079846

3

Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.

Sherban A, Raanani P, Gurion R, Wolach O, Gafter-Gvili A. Sherban A, et al. Leuk Res. 2022 Feb;113:106773. doi: 10.1016/j.leukres.2021.106773. Epub 2021 Dec 31. Leuk Res. 2022. PMID: 35066294

4

Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML - A systematic review.

Sherban A, Fredman D, Shimony S, Yeshurun M, Raanani P, Stahl M, Gafter-Gvili A, Wolach O. Sherban A, et al. Leuk Res. 2023 Oct;133:107368. doi: 10.1016/j.leukres.2023.107368. Epub 2023 Aug 4. Leuk Res. 2023. PMID: 37598660

5

[TREATMENT WITH DUAL ANTIPLATELET THERAPY FOR SECONDARY PREVENTION OF STROKE - PROS AND CONS].

Sherban A, Armon C, Rapoport M. Sherban A, et al. Harefuah. 2018 Dec;157(12):773-778. Harefuah. 2018. PMID: 30582310 Review. Hebrew.

6

Racial Disparities in Inpatient Consult Services: A Retrospective Analysis.

Sherban A, Critchlow E, Douglas A, Keller M. Sherban A, et al. Skinmed. 2024 Oct 22;22(5):404-406. eCollection 2024. Skinmed. 2024. PMID: 39433534 No abstract available.

7

Application of SBIRT Tools in Managing Alcohol and Drug Use Disorders.

Tsarev S, Sherban A, Izmalkov N, Benian A, Gayduk A. Tsarev S, et al. Among authors: sherban a. Psychiatr Danub. 2024 Sep;36(Suppl 2):381-384. Psychiatr Danub. 2024. PMID: 39378500 Free article.

8

Recurrence of Metastatic Crohn's Disease after Surgical Resection.

Sherban A, Keller M. Sherban A, et al. Skinmed. 2023 Nov 10;21(5):366-369. eCollection 2023. Skinmed. 2023. PMID: 37945367

9

Quality of Life in Dermatology Patients on Anti-Cytokine Biologics during the COVID-19 Pandemic.

Sherban A, Brockmeyer K, Cross D, Keller M. Sherban A, et al. Skinmed. 2023 Sep 29;21(4):294-298. eCollection 2023. Skinmed. 2023. PMID: 37771028 No abstract available.

10

Telehealth and Inpatient Dermatology Consults: Results of Surveys to Primary Providers during the COVID-19 Pandemic.

Sherban A, Keller M. Sherban A, et al. Skinmed. 2023 Aug 28;21(3):216-218. eCollection 2023. Skinmed. 2023. PMID: 37634113 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters